Paul Mahon - EVP & General Counsel, United Therapeutics Corp

As of January 21, 2022


Paul Mahon Net Worth

  • Net worth is estimated to be at least $108.34M
  • Owns at least 30,369 units of United Therapeutics Corp stock
  • Sold an estimated value of $162.96M in the last 18 years at United Therapeutics Corp

Paul Mahon Trading

  • Largest purchase of shares was 72,000 units , worth over $1.82M on February 6, 2012
  • Largest sale of shares was 72,000 units , worth over $3.6M on February 6, 2012
  • In total has made about 227 transactions over 18 years
  • Usually trades in March, with the busiest year in 2014
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

United Therapeutics Corp Insider Trading

  • The most recent transaction was 6,000 units sold on January 21, 2022 by Paul Mahon worth over $1.23M
  • In the last 19 years, insiders at United Therapeutics Corp sold an estimated value of $1.27B and bought an estimated value of $462.78M
  • The most active traders are Martine Rothblatt, Chairperson & CEO,  Paul Mahon, EVP & General Counsel,  and Roger Jeffs
  • Insider trading is most common in June, with the busiest year in 2015

UNITED THERAPEUTICS Corp Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1